DZ3022A1 - Composition pharmaceutique de résorcinol, et procédé pour sa préparation. - Google Patents

Composition pharmaceutique de résorcinol, et procédé pour sa préparation.

Info

Publication number
DZ3022A1
DZ3022A1 DZ000048A DZ000048A DZ3022A1 DZ 3022 A1 DZ3022 A1 DZ 3022A1 DZ 000048 A DZ000048 A DZ 000048A DZ 000048 A DZ000048 A DZ 000048A DZ 3022 A1 DZ3022 A1 DZ 3022A1
Authority
DZ
Algeria
Prior art keywords
resorcinol
preparation
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
DZ000048A
Other languages
English (en)
French (fr)
Inventor
Eric William Collington
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ3022A1 publication Critical patent/DZ3022A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/03—Liquid compositions with two or more distinct layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DZ000048A 1999-03-22 2000-03-21 Composition pharmaceutique de résorcinol, et procédé pour sa préparation. DZ3022A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12555399P 1999-03-22 1999-03-22

Publications (1)

Publication Number Publication Date
DZ3022A1 true DZ3022A1 (fr) 2004-03-27

Family

ID=22420269

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ000048A DZ3022A1 (fr) 1999-03-22 2000-03-21 Composition pharmaceutique de résorcinol, et procédé pour sa préparation.

Country Status (45)

Country Link
EP (1) EP1165031B1 (xx)
JP (1) JP2002539234A (xx)
KR (1) KR100468250B1 (xx)
CN (1) CN1213726C (xx)
AP (1) AP1413A (xx)
AR (1) AR018475A1 (xx)
AT (1) ATE297187T1 (xx)
AU (1) AU765209B2 (xx)
BG (1) BG65146B1 (xx)
BR (1) BR0009194A (xx)
CA (1) CA2366623C (xx)
CO (1) CO5160291A1 (xx)
CR (1) CR6452A (xx)
CZ (1) CZ298939B6 (xx)
DE (1) DE60020682T2 (xx)
DZ (1) DZ3022A1 (xx)
EA (1) EA003866B1 (xx)
EE (1) EE200100489A (xx)
ES (1) ES2241580T3 (xx)
GE (1) GEP20043231B (xx)
GT (1) GT200000030A (xx)
HK (1) HK1044478B (xx)
HN (1) HN2000000033A (xx)
HR (1) HRP20010696A2 (xx)
HU (1) HUP0200684A3 (xx)
ID (1) ID30272A (xx)
IL (1) IL144848A0 (xx)
IS (1) IS6052A (xx)
MA (1) MA26726A1 (xx)
MY (1) MY133193A (xx)
NO (1) NO20014586L (xx)
NZ (1) NZ513453A (xx)
OA (1) OA11840A (xx)
PA (1) PA8492001A1 (xx)
PE (1) PE20001567A1 (xx)
PL (1) PL350905A1 (xx)
PT (1) PT1165031E (xx)
SK (1) SK285434B6 (xx)
TN (1) TNSN00055A1 (xx)
TR (1) TR200102741T2 (xx)
TW (1) TWI224011B (xx)
UY (1) UY26072A1 (xx)
WO (1) WO2000056279A1 (xx)
YU (1) YU67101A (xx)
ZA (1) ZA200106681B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2816843B1 (fr) * 2000-11-23 2006-10-27 Actichem Inhibiteurs de l'enzyme 5 alpha-reductase
US20040109832A1 (en) * 2002-12-09 2004-06-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Di-substituted resorcinols as skin lightening agents
DE10324566A1 (de) * 2003-05-30 2004-12-16 Symrise Gmbh & Co. Kg Verwendung von Diphenylmethan-Derivaten als Tyrosinase-Inhibitoren
FR2894582B1 (fr) 2005-12-12 2008-02-22 Fabre Pierre Dermo Cosmetique Sirna anti myosine va et depigmentation de la peau
FR2939136B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2939135B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
JP2018510905A (ja) * 2015-02-16 2018-04-19 エグザンシャル 皮膚障害の予防又は治療のための組成物
CN107846880A (zh) 2015-07-14 2018-03-27 荷兰联合利华有限公司 抗微生物组合物
IT201700104536A1 (it) 2017-09-19 2019-03-19 Cmed Aesthetics Srl Prodotti topici con sistema bifasico

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526179A (en) * 1983-01-28 1985-07-02 Leonard Salesky Digital apical foramen locating apparatus
JPH0651619B2 (ja) * 1988-05-09 1994-07-06 株式会社クラレ 美白剤
JP2875374B2 (ja) * 1990-10-31 1999-03-31 ポーラ化成工業株式会社 ニキビ用化粧料
JPH054905A (ja) * 1990-10-31 1993-01-14 Pola Chem Ind Inc 化粧料
FR2679133B1 (fr) * 1991-07-17 1993-10-15 Oreal Utilisation de derives d'acides (2,5-dihydroxyphenyl)carboxyliques, leurs homologues et leurs sels dans la preparation d'une composition cosmetique ou dermatologique a action depigmentante.
JP2790986B2 (ja) * 1995-02-27 1998-08-27 住友建設株式会社 橋脚の構築方法及び施工方法
BR9803596A (pt) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.

Also Published As

Publication number Publication date
PA8492001A1 (es) 2002-02-21
NZ513453A (en) 2003-04-29
HRP20010696A2 (en) 2002-08-31
CN1344152A (zh) 2002-04-10
PL350905A1 (en) 2003-02-10
WO2000056279A1 (en) 2000-09-28
EP1165031B1 (en) 2005-06-08
IL144848A0 (en) 2002-06-30
CA2366623C (en) 2006-06-13
SK13222001A3 (sk) 2002-08-06
CA2366623A1 (en) 2000-09-28
ZA200106681B (en) 2002-08-14
CZ298939B6 (cs) 2008-03-19
AU2823000A (en) 2000-10-09
HN2000000033A (es) 2001-02-02
HK1044478B (zh) 2005-12-09
AU765209B2 (en) 2003-09-11
PE20001567A1 (es) 2001-01-13
CN1213726C (zh) 2005-08-10
CO5160291A1 (es) 2002-05-30
ES2241580T3 (es) 2005-11-01
PT1165031E (pt) 2005-09-30
GEP20043231B (en) 2004-05-25
AR018475A1 (es) 2001-11-14
NO20014586L (no) 2001-11-21
CZ20013339A3 (cs) 2002-07-17
IS6052A (is) 2001-08-17
DE60020682T2 (de) 2006-04-06
OA11840A (en) 2005-08-22
UY26072A1 (es) 2000-10-31
KR20010114233A (ko) 2001-12-31
EA003866B1 (ru) 2003-10-30
ATE297187T1 (de) 2005-06-15
AP2001002273A0 (en) 2001-09-30
EE200100489A (et) 2002-12-16
BR0009194A (pt) 2001-12-18
CR6452A (es) 2004-03-24
GT200000030A (es) 2001-09-08
YU67101A (sh) 2004-12-31
HUP0200684A3 (en) 2009-11-30
KR100468250B1 (ko) 2005-01-27
ID30272A (id) 2001-11-15
EP1165031A1 (en) 2002-01-02
DE60020682D1 (de) 2005-07-14
NO20014586D0 (no) 2001-09-21
EA200100853A1 (ru) 2002-02-28
MY133193A (en) 2007-10-31
HK1044478A1 (en) 2002-10-25
JP2002539234A (ja) 2002-11-19
HUP0200684A2 (en) 2002-08-28
AP1413A (en) 2005-03-18
BG106016A (en) 2002-05-31
TR200102741T2 (tr) 2002-01-21
SK285434B6 (sk) 2007-01-04
TNSN00055A1 (fr) 2005-11-10
BG65146B1 (bg) 2007-04-30
TWI224011B (en) 2004-11-21
MA26726A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
CH689805A8 (fr) Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
DZ2963A1 (fr) Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2634A1 (fr) Dérivés de pleuromutiline nouveaux procédé pour leur préparation et compositions pharmaceutiques lescontenant.
DZ2891A1 (fr) Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26659A1 (fr) Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2197A1 (fr) Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2866A1 (fr) 1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2773A1 (fr) Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2457A1 (fr) Derivés de nicotinamide nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
DZ2890A1 (fr) 4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3009A1 (fr) Dérivés de quinoléine-2-one à substituant hétéroaryle nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3020A1 (fr) Acides oxamiques nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1889A1 (fr) Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3045A1 (fr) Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3038A1 (fr) Modulateurs nouveaux des récepteurs de glucocorticoïdes, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2923A1 (fr) Formulations pharmaceutiques d'inhibiteurs de pde-5 de gmpc à libération contrôlée, et procédé pour leur préparation.
DZ3042A1 (fr) Dérivés d'isothiazole nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26630A1 (fr) 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ3079A1 (fr) Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé.
DZ2777A1 (fr) Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2712A1 (fr) Composition de mésylate de trovafloxacine et procédé pour sa préparation.
DZ2751A1 (fr) Composés calciolytiques nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
DZ2155A1 (fr) Aazétidines, procédé pour leur préparation, et co mpositions pharmaceutiques les contenant.
DZ3041A1 (fr) Composition pharmaceutique nouvelle comprenant un inhibiteur de nos, et procédé pour sa préparation.
DZ3023A1 (fr) Dérivés de résorcinol, compositions pharmaceutiques les contenant et procédé pour leur préparation.